CIBC World Markets Inc. acquired a new position in Cantel Medical Corp. (NYSE:CMN) during the third quarter, Holdings Channel reports. The institutional investor acquired 38,363 shares of the company’s stock, valued at approximately $2,992,000. CIBC World Markets Inc. owned about 0.09% of Cantel Medical Corp. as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of CMN. Great West Life Assurance Co. Can increased its stake in shares of Cantel Medical Corp. by 5.0% in the third quarter. Great West Life Assurance Co. Can now owns 48,746 shares of the company’s stock worth $3,799,000 after buying an additional 2,329 shares during the last quarter. State Street Corp increased its position in Cantel Medical Corp. by 1.4% in the first quarter. State Street Corp now owns 698,437 shares of the company’s stock valued at $49,838,000 after buying an additional 9,417 shares in the last quarter. Conestoga Capital Advisors LLC increased its position in Cantel Medical Corp. by 2.4% in the third quarter. Conestoga Capital Advisors LLC now owns 622,550 shares of the company’s stock valued at $48,546,000 after buying an additional 14,370 shares in the last quarter. Acrospire Investment Management LLC increased its position in Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock valued at $102,000 after buying an additional 500 shares in the last quarter. Finally, Kalmar Investments Inc. DE increased its position in Cantel Medical Corp. by 68.4% in the second quarter. Kalmar Investments Inc. DE now owns 285,232 shares of the company’s stock valued at $19,604,000 after buying an additional 115,832 shares in the last quarter. 83.25% of the stock is owned by hedge funds and other institutional investors.
Cantel Medical Corp. (NYSE:CMN) traded up 0.85% during trading on Friday, reaching $81.87. The company’s stock had a trading volume of 74,132 shares. The company has a market capitalization of $3.39 billion, a P/E ratio of 56.93 and a beta of 1.41. Cantel Medical Corp. has a 1-year low of $55.01 and a 1-year high of $82.80. The company’s 50-day moving average is $75.06 and its 200-day moving average is $72.23.
Cantel Medical Corp. (NYSE:CMN) last issued its quarterly earnings data on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The business had revenue of $179 million for the quarter. During the same quarter in the prior year, the company earned $0.39 earnings per share. The firm’s revenue was up 18.3% compared to the same quarter last year. Equities analysts anticipate that Cantel Medical Corp. will post $1.96 EPS for the current year.
The business also recently disclosed a semiannual dividend, which will be paid on Tuesday, January 31st. Stockholders of record on Tuesday, January 17th will be given a $0.07 dividend. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06. This represents a dividend yield of 0.18%. The ex-dividend date is Thursday, January 12th. Cantel Medical Corp.’s dividend payout ratio is currently 8.33%.
Several equities analysts have weighed in on the company. Benchmark Co. set a $83.00 target price on Cantel Medical Corp. and gave the company a “buy” rating in a research report on Saturday, October 1st. Needham & Company LLC assumed coverage on Cantel Medical Corp. in a research report on Wednesday, August 24th. They issued a “hold” rating for the company.
In related news, Director Ann E. Berman sold 1,453 shares of the stock in a transaction dated Friday, September 30th. The stock was sold at an average price of $77.56, for a total transaction of $112,694.68. Following the transaction, the director now directly owns 5,424 shares in the company, valued at $420,685.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Charles M. Diker sold 14,897 shares of the stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $78.76, for a total value of $1,173,287.72. Following the transaction, the chairman now owns 3,190,111 shares in the company, valued at $251,253,142.36. The disclosure for this sale can be found here. 15.30% of the stock is owned by insiders.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.